Start with what you need treated.

Corneal transplantation, or keratoplasty, replaces the eye's clear front surface (cornea) when it has become scarred, clouded, thinned, or otherwise damaged from disease, injury, or infection, significantly restoring vision that has been impaired by the compromised cornea. Depending on which layers of the cornea are affected, the surgeon may perform a full-thickness transplant or a more selective partial-thickness procedure that replaces only the diseased corneal layers while preserving healthy tissue. The procedure is performed under local or general anesthesia and typically takes one to two hours. Patients use anti-rejection eye drops for an extended period after surgery, sometimes for a year or longer, to help the body accept the new corneal tissue. Vision gradually improves over several months as the eye heals and any stitches are selectively removed to fine-tune the eye's shape. With modern techniques, the majority of corneal transplants are successful, providing substantial visual improvement and preserving the eye's structural integrity.

Implantable Collamer Lens (ICL) surgery places a thin, biocompatible lens inside the eye, positioned between the iris and the natural lens, to correct significant nearsightedness, farsightedness, or astigmatism, particularly for patients with very high refractive errors or thin corneas that make them unsuitable candidates for LASIK. The procedure is performed under local anesthesia using numbing eye drops, through a very small incision, with the folded lens unfolding into position once inside the eye. Each eye typically takes 15 to 30 minutes to treat, often performed on separate days for each eye. Because the natural lens remains untouched and the eye's cornea is not reshaped, unlike LASIK, this procedure is reversible if needed in the future. Vision improvement is often immediate or within a day or two, with most patients achieving excellent, sharp vision. Regular eye examinations are recommended after surgery to monitor eye pressure and long-term lens position.

Blade-free LASIK, also called all-laser LASIK, uses a femtosecond laser to create the thin corneal flap, replacing the mechanical blade (microkeratome) used in traditional LASIK, allowing for a more precise, customized, and safer flap creation. A second laser, the excimer laser, then reshapes the underlying corneal tissue to correct the specific refractive error, based on detailed pre-operative measurements of the eye. The entire procedure for both eyes typically takes about 15 to 20 minutes, performed under topical anesthesia using numbing eye drops, with the patient awake and comfortable throughout. Most patients notice significantly improved vision within hours of the procedure, with vision continuing to stabilize and sharpen over the following days to weeks. Mild dryness or light sensitivity is common initially, managed with lubricating eye drops. The vast majority of patients achieve excellent uncorrected vision, often reducing or eliminating their need for glasses or contact lenses entirely.

Blepharoplasty addresses excess, sagging skin and puffiness around the eyes, whether affecting the upper eyelids, which can sometimes obstruct peripheral vision when severe, or the lower eyelids, where under-eye bags are a common cosmetic concern. The surgeon carefully removes excess skin, and where appropriate, underlying fat or muscle, through incisions placed within the natural creases of the eyelid to minimize visible scarring. The procedure is performed under local anesthesia with sedation and typically takes one to two hours depending on whether one or both eyelids are treated. Swelling and bruising are common for one to two weeks following surgery, with cold compresses recommended to help reduce this during initial recovery. Most patients return to normal activities within ten days to two weeks, with final results visible once residual swelling resolves over several weeks. Results are generally long-lasting, providing a more refreshed, youthful eye appearance and, when medically indicated, improved peripheral vision.

Cataract surgery removes the eye's natural lens once it has become clouded (a cataract), a common age-related change that progressively blurs and dims vision, replacing it with a clear artificial intraocular lens tailored to the patient's specific visual needs. The most common technique, phacoemulsification, uses ultrasound energy delivered through a very small incision to break up and remove the cloudy lens before inserting the folded artificial lens, which unfolds into position within the eye. The procedure is performed under local anesthesia using numbing eye drops, typically taking just 15 to 20 minutes per eye, with each eye usually treated on a separate occasion. Most patients notice improved vision within a day or two, with full visual stabilization over the following few weeks. Mild discomfort, light sensitivity, and blurry vision immediately after surgery are normal and resolve quickly. Cataract surgery is one of the most commonly performed and highly successful surgical procedures, with the vast majority of patients achieving significantly improved vision.

Deep Anterior Lamellar Keratoplasty (DALK) is a selective corneal transplant technique used to treat conditions affecting the front layers of the cornea, such as keratoconus or corneal scarring, while carefully preserving the patient's own healthy innermost corneal layer (the endothelium), which is responsible for keeping the cornea clear. By retaining this important layer, DALK offers a lower risk of transplant rejection compared to traditional full-thickness corneal transplants, since the endothelial layer that is most commonly involved in rejection episodes is not replaced. The procedure is performed under local or general anesthesia and is technically more demanding than full-thickness transplant, typically taking one to two hours. Recovery involves a gradual healing process over several months, with vision improving progressively as the eye heals and sutures are selectively adjusted or removed. Anti-rejection eye drops are still used after surgery, though often for a shorter duration than with full-thickness transplants. Most patients achieve good visual outcomes with the added benefit of a lower long-term rejection risk.

Diabetic retinopathy treatment is tailored to the stage and severity of retinal blood vessel damage caused by prolonged high blood sugar levels, with treatment options including laser photocoagulation to seal leaking blood vessels or reduce abnormal vessel growth, injectable medications delivered directly into the eye to reduce swelling and abnormal vessel growth, or surgery for more advanced cases involving bleeding or retinal detachment. Laser treatment and eye injections are performed in an outpatient setting under local anesthesia using numbing eye drops, with each session typically taking 15 to 30 minutes and often requiring a series of treatments over time to achieve and maintain the best results. More advanced disease requiring surgery, called a vitrectomy, is performed under local or general anesthesia to remove blood or scar tissue from within the eye. Strict control of blood sugar, blood pressure, and cholesterol levels remains a critical part of managing this condition alongside direct eye treatment. Regular, ongoing eye examinations are essential for all patients with diabetes to detect and treat retinopathy early, since timely treatment can prevent significant vision loss.

Eye cancer treatment varies significantly depending on the specific type of cancer, which can range from melanoma of the eye's pigmented tissue to lymphoma or cancers affecting the eyelid, and the treatment approach is carefully individualized to balance effective cancer control with preservation of vision and the eye itself whenever safely achievable. Smaller, localized tumors are often treated with targeted radiation therapy, such as plaque radiotherapy which places a small radioactive disc directly over the tumor, or laser treatment, both aimed at destroying the tumor while sparing surrounding healthy eye tissue. Larger or more advanced tumors may require surgical removal of the tumor alone, or in the most severe cases, removal of the entire eye (enucleation) when the cancer cannot be controlled by other means. Treatment is coordinated by a specialized ocular oncology team, with the specific care setting and recovery time varying considerably based on the treatment approach used. Regular, long-term follow-up with eye examinations and sometimes body imaging monitors for local recurrence and screens for cancer spread to other parts of the body. Early detection through regular eye examinations significantly improves the chances of successful, eye-preserving treatment.

Glaucoma treatment aims to lower elevated pressure within the eye, which if left uncontrolled can progressively damage the optic nerve and lead to irreversible vision loss, typically beginning with prescription eye drops that either reduce fluid production within the eye or improve its drainage. For patients whose pressure is not adequately controlled with drops alone, or who have difficulty maintaining a consistent drop regimen, laser treatments such as selective laser trabeculoplasty can help improve the eye's natural drainage system, performed quickly in an outpatient setting under topical anesthesia. When medication and laser treatment are insufficient, surgical options, including trabeculectomy or minimally invasive glaucoma surgery, create new drainage pathways to lower eye pressure more definitively. Regular monitoring of eye pressure, optic nerve appearance, and visual field testing tracks disease progression and treatment effectiveness over time, since glaucoma is typically a lifelong condition requiring ongoing management. While vision already lost to glaucoma cannot be restored, appropriate, consistent treatment is highly effective at preventing further vision loss and preserving remaining sight for the vast majority of patients.

Intacs corneal implants are thin, curved plastic segments inserted into the middle layer of the cornea to flatten and reshape its surface, primarily used to treat keratoconus, a progressive condition where the cornea thins and bulges into an irregular cone shape, causing distorted vision. The surgeon creates a small channel within the cornea, often using a precise femtosecond laser, and carefully places the segments to help normalize the corneal curvature and improve visual clarity. The procedure is performed under local anesthesia using numbing eye drops and typically takes 15 to 30 minutes per eye. Vision often improves within a few days as the cornea adjusts to the implants, with the segments themselves being removable or exchangeable if needed in the future. This procedure can significantly improve both uncorrected vision and the fit of contact lenses for many patients with keratoconus, while also potentially slowing disease progression and delaying or avoiding the need for a full corneal transplant. Regular follow-up monitors both vision and the overall progression of the underlying keratoconus.

Laser iridotomy treats or prevents a specific type of glaucoma called angle-closure glaucoma, where the drainage angle of the eye becomes blocked by the iris, potentially causing a sudden, painful, and sight-threatening rise in eye pressure. Using a laser focused precisely on the iris, the ophthalmologist creates a tiny opening that allows fluid within the eye to flow more freely, relieving the pressure buildup that occurs when the drainage angle becomes narrowed or blocked. The procedure is performed under local anesthesia using numbing eye drops and is very quick, typically taking just a few minutes per eye. Patients may notice mild discomfort or light sensitivity for a short period afterward, but there is minimal downtime, with most returning to normal activities the same day. This preventive or treatment procedure is highly effective at reducing the risk of an acute angle-closure glaucoma attack, a medical emergency that can cause rapid, permanent vision loss if untreated. Regular follow-up monitors eye pressure and the drainage angle to ensure continued effectiveness of the treatment.

This combined procedure addresses both cataracts and glaucoma in patients who have both conditions simultaneously, performing phacoemulsification cataract removal, where the clouded natural lens is broken up using ultrasound energy and replaced with a clear artificial lens, along with trabeculectomy, which creates a new drainage channel to reduce elevated eye pressure associated with glaucoma. Performing both procedures together offers the advantage of a single surgical session and recovery period, rather than two separate operations, while still effectively addressing both conditions. The combined surgery is performed under local anesthesia and typically takes 45 minutes to an hour, longer than cataract surgery alone due to the additional glaucoma component. Recovery involves more careful monitoring than cataract surgery alone, since the trabeculectomy drainage site needs to heal properly to function as intended, with several follow-up visits in the following weeks to assess eye pressure and drainage function. Most patients experience improved vision from the cataract removal along with better-controlled eye pressure from the glaucoma component. This combined approach is a well-established, effective option for appropriately selected patients with both cataracts and glaucoma.